Search
Lexeo Therapeutics Inc
LXEOAdd to Watchlist
2.750USD
-0.050-1.79%
Market hours 10/26, 10:15（ET）
225.75MMarket Cap
LossP/E TTM
Lexeo Therapeutics Inc (LXEO) Stock Price Target & Forecast
Analyst Rating
Based on 10 analysts giving stock ratings to Lexeo Therapeutics Inc in the past month.
Strong Buy
6 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
21.000USD+695.45%
LXEO Analyst Recommendation Trends
In the current month, LXEO has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. LXEO average Analyst price target in the last month is 21.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
6
6
6
6
6
6
5
5
4
4
5
5
5
5
5
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
10
11
11
11
11
10
9
LXEO Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Insmed Inc
INSM
7
18
0
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
Biontech SE
BNTX
4
12
8
0
0
24
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
Cytokinetics Inc
CYTK
5
16
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Financial Forecasting
Based on analysts' estimates, LXEO EPS is projected to reach -0.329 in FY2026Q3, following reported EPS of -0.302 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.31
-0.31
-0.28
-0.33
-0.34
Actual
-0.27
-0.25
-0.30
--
--
Surprise
+13.19%
+20.60%
-6.00%
--
--
FAQs
What is Lexeo Therapeutics Inc's price target?
Analysts forecast that Lexeo Therapeutics Inc's price target is USD 21.00, with the highest forecast at USD 28.00 and the lowest forecast at USD 15.00.
How have Lexeo Therapeutics IncLXEO's recent earnings per share performed?
The market expectation was USD -0.30, while Lexeo Therapeutics IncLXEO's earnings per share (EPS) for the previous quarter was USD -0.25. EPS for the next quarter is expected at USD -0.33.
What is the analyst rating for Lexeo Therapeutics Inc?
Based on the ratings of Lexeo Therapeutics Inc's stock from 10 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.